Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. financial statements

Larimar Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 165.67M10-K
Cash and equivalentsUSD 85.41M10-Q
Total debtUSD 4.07MEODHD

Larimar Therapeutics, Inc. financials on 6ix · Larimar Therapeutics, Inc. on 6ix